somnio is a German digital therapy app for insomnia, based on cognitive behavioural therapy for insomnia (CBT-I) with twelve interactive modules and a central sleep diary. The Federal Institute for Drugs and Medical Devices (BfArM) has approved it permanently as a digital health application (DiGA), so statutory health insurers can cover it on prescription. It is also offered as a self-pay service.
somnio is developed by mementor DE GmbH in Leipzig, a company founded in Switzerland in 2014 and based in Leipzig since 2020. ResMed, a medical technology company based in San Diego, acquired mementor in August 2022 and runs it as a separate business unit in Germany, so the US parent may be subject to US legal requests. The site states GDPR compliance and ISO 27001 certification but does not say where data is hosted. A European organisation should check the hosting location and sub-processors before use.